We are live on ! Find out more
Ninety One (UK)

Ninety One (UK) Portfolio holdings

AUM $44.7B
1-Year Est. Return 17.24%
This Fund
S&P 500
This Quarter Est. Return
+3.73%
1 Year Est. Return
+17.24%
3 Year Est. Return
+87.79%
5 Year Est. Return
+111.34%
10 Year Est. Return
+534.1%
AUM
$16.4B
AUM Growth
-$610M
Cap. Flow
-$818M
Cap. Flow %
-5%
Top 10 Hldgs %
19.37%
Holding
294
New
33
Increased
98
Reduced
124
Closed
20

Top Sells

1
CVX icon
Chevron
CVX
+$202M
2
VZ icon
Verizon
VZ
+$148M
3
IBM icon
IBM
IBM
+$139M
4
DTV
DIRECTV COM STK (DE)
DTV
+$136M
5
PFE icon
Pfizer
PFE
+$124M

Sector Composition

1 Healthcare 18.49%
2 Financials 17.95%
3 Technology 17.62%
4 Energy 12.77%
5 Industrials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WX
76
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
$78.8M 0.48%
2,341,716
+47,630
+2% +$1.68M
GRMN
77
Garmin
GRMN
$48.5B
$78.4M 0.48%
+1,484,769
New +$80.7M
TW
78
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
$77.2M 0.47%
682,148
-11,709
-2% -$1.29M
AWH
79
DELISTED
Allied World Assurance Co Hld Lt
AWH
$76.9M 0.47%
2,027,858
-62,669
-3% -$2.35M
FDS icon
80
Factset
FDS
$9.13B
$73.6M 0.45%
522,776
+89,497
+21% +$11.9M
COP icon
81
ConocoPhillips
COP
$139B
$73M 0.45%
1,056,761
-363,766
-26% -$25.4M
TSM icon
82
TSMC
TSM
$2.06T
$72.2M 0.44%
3,228,738
-880,530
-21% -$19.2M
BHI
83
DELISTED
Baker Hughes
BHI
$70.5M 0.43%
1,257,990
-438,739
-26% -$24.7M
XOM icon
84
ExxonMobil
XOM
$614B
$68.1M 0.42%
736,838
+15,704
+2% +$1.46M
XRX icon
85
Xerox
XRX
$354M
$68M 0.42%
1,861,869
-76,450
-4% -$2.7M
TAP icon
86
Molson Coors Class B
TAP
$7.91B
$67.7M 0.41%
908,526
-6,588
-0.7% -$489K
MD icon
87
Pediatrix Medical
MD
$2.15B
$67.1M 0.41%
1,014,655
-69,153
-6% -$4.22M
AFG icon
88
American Financial Group
AFG
$11.9B
$65.4M 0.4%
1,076,384
-18,175
-2% -$1.08M
DHR icon
89
Danaher
DHR
$144B
$63.4M 0.39%
1,100,906
-91,541
-8% -$4.96M
HP icon
90
Helmerich & Payne
HP
$3.35B
$60.4M 0.37%
895,172
-527,219
-37% -$41.1M
VC icon
91
Visteon
VC
$2.81B
$59.6M 0.36%
557,633
-3,775
-0.7% -$364K
DAN icon
92
Dana Inc
DAN
$2.88B
$58.9M 0.36%
2,708,631
-43,863
-2% -$886K
APC
93
DELISTED
Anadarko Petroleum
APC
$57.7M 0.35%
699,317
-51,908
-7% -$4.52M
PG icon
94
Procter & Gamble
PG
$355B
$55.8M 0.34%
612,213
+11,098
+2% +$976K
BKNG icon
95
Booking.com
BKNG
$139B
$55.5M 0.34%
1,217,175
+454,025
+59% +$20.5M
PSX icon
96
Phillips 66
PSX
$82.1B
$54.7M 0.33%
763,481
+289,710
+61% +$21.4M
CHE icon
97
Chemed
CHE
$6.74B
$54.2M 0.33%
513,224
+111,282
+28% +$11.8M
CVX icon
98
Chevron
CVX
$371B
$53.3M 0.33%
475,409
-1,774,627
-79% -$202M
BBD icon
99
Banco Bradesco
BBD
$37.7B
$51.9M 0.32%
9,900,882
+795,503
+9% +$4.46M
TIME
100
DELISTED
Time Inc.
TIME
$47.8M 0.29%
1,940,804
+59,497
+3% +$1.35M

Similar funds

Ninety One (UK)'s Q4 2014 Portfolio in Review

As of Q4 2014, Ninety One (UK) held 294 positions worth $16.4B, down 3.6% from $17B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ninety One (UK) withdrew a net $818M in Q4 2014, closing 20 positions and reducing 124 holdings. Its most notable exit was SALIX PHARMACEUTICALS LTD DEL, an estimated $95.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

Against the trend, Ninety One (UK) opened a new position in Quest Diagnostics worth $117M.

  • Ninety One (UK)'s largest Q4 2014 buy was Quest Diagnostics: 1,751,194 shares worth $117M.
  • Ninety One (UK) added most to American International in Q4 2014, an estimated $120M increase.
  • Ninety One (UK)'s biggest Q4 2014 reduction was Chevron, cutting an estimated $202M.
  • Ninety One (UK) fully exited SALIX PHARMACEUTICALS LTD DEL in Q4 2014, selling an estimated $95.1M.
  • Ninety One (UK)'s ten largest holdings make up 19% of its $16.4B portfolio in Q4 2014.
  • Ninety One (UK) opened 33 new positions and closed 20 in Q4 2014.
  • Ninety One (UK)'s portfolio value fell 3.6% quarter-over-quarter to $16.4B.

Based on Ninety One (UK)'s 13F filing for Q4 2014, filed 13 Feb 2015.